Reversal of the disease signature in prurigo nodularis by blocking the itch cytokine

Affiliations

¹ Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Dermatology and Venereology Division, Department of Medicine Solna, Karolinska Institutet, Solna, Sweden. Electronic address: eniko.sonkoly@medsci.uu.se.

Editorial

Enikö Sonkoly. J Allergy Clin Immunol. 2022 Apr.

. 2022 Apr;149(4):1213-1215.

doi: 10.1016/j.jaci.2022.02.009. Epub 2022 Feb 18.

¹ Department of Medical Sciences, Uppsala University, Uppsala, Sweden; Dermatology and Venereology Division, Department of Medicine Solna, Karolinska Institutet, Solna, Sweden. Electronic address: eniko.sonkoly@medsci.uu.se.

No abstract available

Keywords: IL-31; IL-31RA; Prurigo nodularis; inflammation; itch; nemolizumab; transcriptome.

Comment on

Transcriptomic characterization of prurigo nodularis and the therapeutic response to nemolizumab.
Tsoi LC, Hacini-Rachinel F, Fogel P, Rousseau F, Xing X, Patrick MT, Billi AC, Berthier CC, Kahlenberg JM, Lazzari A, Wiegmann H, Ständer S, Piketty C, Julia V, Krishnaswamy JK, Gudjonsson JE. Tsoi LC, et al. J Allergy Clin Immunol. 2022 Apr;149(4):1329-1339. doi: 10.1016/j.jaci.2021.10.004. Epub 2021 Nov 29. J Allergy Clin Immunol. 2022. PMID: 34857395 Free PMC article.